• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征瘦型女性心血管风险预测指标:高敏C反应蛋白和纤溶酶原激活物抑制剂-1的前瞻性病例对照研究

Cardiovascular Risk Predictors High Sensitivity C-Reactive Protein and Plasminogen Activator Inhibitor-1 in Women with Lean Phenotype of Polycystic Ovarian Syndrome: A Prospective Case-Control Study.

作者信息

Shah Ashok K, Yadav Birendra K, Shah Amrendra K, Suri Arpita, Deo Saurabh K

机构信息

Department of Biochemistry, Faculty of Medicine and Health Sciences, Adesh Medical College and Hospital, Shahbad, Haryana, India.

Department of Biochemistry, Faculty of Medicine and Health Sciences, Banas Medical College and Research Institute, Palanpur, Gujrat, India.

出版信息

J Lab Physicians. 2022 Jul 26;15(1):31-37. doi: 10.1055/s-0042-1750066. eCollection 2023 Mar.

DOI:10.1055/s-0042-1750066
PMID:37064963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10104710/
Abstract

Accumulating evidence suggests increased cardiovascular risk in women with polycystic ovarian syndrome (PCOS) due to a cluster of factors, such as obesity, lipid abnormalities, impaired glucose tolerance (IGT), and hypertension. Markers such as high-sensitivity C-reactive protein (hs-CRP) and plasminogen activator inhibitor-1 (PAI-1) can provide an adjunctive method for the assessment of cardiovascular risk and can indicate future coronary heart diseases in women with lean PCOS.  In this prospective case-control study, women clinically diagnosed with PCOS (  = 25) with normal body mass index (BMI) and age and BMI-matched healthy controls (  = 75) were enrolled. The quantitative data were expressed as mean ± standard deviation (SD). Unpaired Student's -test was used to compare the values (PCOS vs. controls) and Pearson's correlation coefficient was used to elucidate the relationship between the variables.  The mean level of fasting blood sugar, serum total cholesterol, low-density lipoprotein (LDL), thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), hs-CRP, and PAI-1 were significantly increased in PCOS patients (  < 0.000) compared with the control patients. Of the reported cases, 54.16% had hs-CRP levels greater than 3 mg/L. When the cases were further divided into normal (  = 20) and IGT (  = 5), hs-CRP values were significantly higher in IGT group as compared with normal glucose tolerance (NGT) group. On bivariate correlation analysis, hs-CRP had significant correlations with PAI-1 (  = 0.41,  < 0.000), waist-to-hip ratio (WHR;  = 0.23,  = 0.02), fasting blood sugar (FBS;  = 0.26,  = 0.009), LDL (  = 0.20,  = 0.03), TSH (  = 0.42,  < 0.000), and LH-to-FSH ratio (  = 0.24,  = 0.01).  Women with lean phenotype of PCOS suffer from many metabolic abnormalities such as abdominal obesity, dyslipidemia, hyperandrogenemia, and insulin resistance. The findings of the study suggest that environment of ongoing low-grade inflammation due to infiltration further exacerbates the metabolic derangements and cardiovascular risk. The investigations as hs-CRP and PAI-1 will help in early identification, diagnosis, and management of cardiovascular diseases associated with lean type of PCOS. These markers can prove to be beneficial in monitoring any unfavorable changes in cardiometabolic profile of such patients.

摘要

越来越多的证据表明,多囊卵巢综合征(PCOS)女性由于肥胖、脂质异常、糖耐量受损(IGT)和高血压等一系列因素,心血管风险增加。高敏C反应蛋白(hs-CRP)和纤溶酶原激活物抑制剂-1(PAI-1)等标志物可为评估心血管风险提供辅助方法,并可提示瘦型PCOS女性未来患冠心病的风险。

在这项前瞻性病例对照研究中,纳入了临床诊断为PCOS(n = 25)且体重指数(BMI)和年龄正常、BMI匹配的健康对照者(n = 75)。定量数据以平均值±标准差(SD)表示。采用非配对学生t检验比较数值(PCOS组与对照组),并使用Pearson相关系数阐明变量之间的关系。

与对照患者相比,PCOS患者的空腹血糖、血清总胆固醇、低密度脂蛋白(LDL)、促甲状腺激素(TSH)、促卵泡激素(FSH)、促黄体生成素(LH)、催乳素(PRL)、hs-CRP和PAI-1的平均水平显著升高(P < 0.000)。在报告的病例中,54.16%的hs-CRP水平大于3 mg/L。当病例进一步分为正常(n = 20)和IGT(n = 5)两组时,IGT组的hs-CRP值显著高于正常糖耐量(NGT)组。在双变量相关分析中,hs-CRP与PAI-1(r = 0.41,P < 0.000)、腰臀比(WHR;r = 0.23,P = 0.02)、空腹血糖(FBS;r = 0.26,P = 0.009)、LDL(r = 0.20,P = 0.03)、TSH(r = 0.42,P < 0.000)和LH与FSH比值(r = 0.24,P = 0.01)显著相关。

瘦型PCOS女性存在许多代谢异常,如腹部肥胖、血脂异常、高雄激素血症和胰岛素抵抗。研究结果表明,由于浸润导致的持续低度炎症环境进一步加剧了代谢紊乱和心血管风险。hs-CRP和PAI-1等检测有助于早期识别、诊断和管理与瘦型PCOS相关的心血管疾病。这些标志物在监测此类患者心脏代谢状况的任何不利变化方面可能是有益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/10104710/607682ae64eb/10-1055-s-0042-1750066-i21100890-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/10104710/607682ae64eb/10-1055-s-0042-1750066-i21100890-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/10104710/607682ae64eb/10-1055-s-0042-1750066-i21100890-1.jpg

相似文献

1
Cardiovascular Risk Predictors High Sensitivity C-Reactive Protein and Plasminogen Activator Inhibitor-1 in Women with Lean Phenotype of Polycystic Ovarian Syndrome: A Prospective Case-Control Study.多囊卵巢综合征瘦型女性心血管风险预测指标:高敏C反应蛋白和纤溶酶原激活物抑制剂-1的前瞻性病例对照研究
J Lab Physicians. 2022 Jul 26;15(1):31-37. doi: 10.1055/s-0042-1750066. eCollection 2023 Mar.
2
A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome.多囊卵巢综合征女性脂蛋白-a和纤溶酶原激活物抑制剂-1的研究。
Horm Mol Biol Clin Investig. 2022 Apr 20;43(3):357-361. doi: 10.1515/hmbci-2021-0044. eCollection 2022 Sep 1.
3
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).印度患有多囊卵巢综合征(PCOS)的青春期女性的高敏C反应蛋白(hs-CRP)水平及其与多囊卵巢综合征各组分的关系。
Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.
4
High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.在非代谢综合征的正常胰岛素血症多囊卵巢患者中,高敏血清 C 反应蛋白及其与其他心血管危险因素的关系。
Arch Gynecol Obstet. 2010 Jun;281(6):1009-14. doi: 10.1007/s00404-009-1226-6. Epub 2009 Sep 22.
5
Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).纤溶酶原激活物抑制剂-1(PAI-1)升高并非多囊卵巢综合征(PCOS)的独立危险因素。
Clin Endocrinol (Oxf). 2000 Apr;52(4):487-92. doi: 10.1046/j.1365-2265.2000.00946.x.
6
Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.多囊卵巢综合征中炎症标志物的临床意义:它们与胰岛素抵抗和体重指数的关系。
Dis Markers. 2009;26(4):163-70. doi: 10.3233/DMA-2009-0627.
7
Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.慢性炎症和高同型半胱氨酸水平与多囊卵巢综合征女性的体重指数增加有关。
Gynecol Endocrinol. 2007 Sep;23(9):505-10. doi: 10.1080/09513590701554306.
8
[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].肥胖型多囊卵巢综合征肥胖女性的临床特征、激素谱及代谢异常
Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71.
9
High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome.高敏C反应蛋白及其与瘦型多囊卵巢综合征患者糖调节受损的关系。
Gynecol Endocrinol. 2012 Apr;28(4):259-63. doi: 10.3109/09513590.2011.613967. Epub 2011 Oct 4.
10
Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.在患有多囊卵巢综合征的瘦女性中,内在因素而非维生素D缺乏与胰岛素抵抗有关。
Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2851-6.

引用本文的文献

1
Spotlight on Proteases: Roles in Ovarian Health and Disease.蛋白酶聚焦:在卵巢健康与疾病中的作用
Cells. 2025 Jun 18;14(12):921. doi: 10.3390/cells14120921.

本文引用的文献

1
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach.瘦素与多囊卵巢综合征(PCOS):基于证据的实用方法。
J Diabetes Metab Disord. 2018 Nov 13;17(2):277-285. doi: 10.1007/s40200-018-0371-5. eCollection 2018 Dec.
2
Role of C-Reactive Protein at Sites of Inflammation and Infection.C-反应蛋白在炎症和感染部位的作用。
Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754. eCollection 2018.
3
The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis.
不同种族育龄妇女多囊卵巢综合征的患病率:一项系统评价和荟萃分析。
Oncotarget. 2017 Jul 12;8(56):96351-96358. doi: 10.18632/oncotarget.19180. eCollection 2017 Nov 10.
4
Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries.肥胖和非肥胖多囊卵巢患者心脏风险标志物水平的评估。
Gynecol Endocrinol. 2017 Jan;33(1):43-47. doi: 10.1080/09513590.2016.1203893. Epub 2016 Jul 16.
5
The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.多囊卵巢综合征不同表型中代谢紊乱的患病率:一项基于伊朗西南部社区的研究
Reprod Biol Endocrinol. 2014 Sep 16;12:89. doi: 10.1186/1477-7827-12-89.
6
The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study.肥胖对多囊卵巢综合征患者炎症标志物的影响:一项 BMI 匹配的病例对照研究。
Arch Gynecol Obstet. 2014 Aug;290(2):315-9. doi: 10.1007/s00404-014-3199-3. Epub 2014 Mar 19.
7
Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.多囊卵巢综合征正常体重女性血清C反应蛋白水平升高。
Hippokratia. 2011 Oct;15(4):323-6.
8
High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt?肥胖症患者的促甲状腺激素(TSH)值偏高:是胰岛素抵抗还是脂肪组织的错?
Obesity (Silver Spring). 2013 Jan;21(1):101-6. doi: 10.1002/oby.20240.
9
PAI-1 and diabetes: a journey from the bench to the bedside.纤溶酶原激活物抑制剂-1与糖尿病:从实验室到临床的历程
Diabetes Care. 2012 Oct;35(10):1961-7. doi: 10.2337/dc12-0638.
10
Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals.脂联素水平是识别非糖尿病个体胰岛素抵抗的有力指标。
Eur J Clin Nutr. 2012 Sep;66(9):1035-8. doi: 10.1038/ejcn.2012.83. Epub 2012 Jul 11.